Skip to content
Baker Capital StrategiesMARKETS. FILINGS. PERSPECTIVE.
Powered by THEMA

Baker Capital Strategies

Free Registration

Register for access to news, tools, alerts and reports.

THEMA Basic included at launch.

Use at least 8 characters.

Home/The Filing Wire/LeMaitre Vascular, Inc./ 4

SEC Filing · 4

LeMaitre Vascular, Inc.

LMATNASDAQEQUITYCurrent

SEC Filing

Filed Jun 5, 2026Accepted Jun 5, 2026, 5:30 PM EDTCIK 1158895Accession 0001193125-26-259990
View company →Permanent SEC source ↗
Share

Company context

LeMaitre is a provider of devices, implants, and services for the treatment of peripheral vascular disease, a condition that affects more than 200 million people worldwide. The Company develops, manufactures, and markets disposable and implantable vascular devices to address the needs of its core customer, the vascular surgeon. LeMaitre is a registered trademark of LeMaitre Vascular, Inc. This press release may include other trademarks and trade names of the Company.

Current securities

LMATNASDAQ · EQUITY · Current

Recent company filings

  1. 10-Q filingAug 5, 2026
  2. Results of Operations and Financial ConditionAug 4, 2026
  3. 144 filingJul 29, 2026
  4. SCHEDULE 13G filingJul 27, 2026
  5. Submission of Matters to a Vote of Security HoldersJun 5, 2026

Document unavailable

This filing is not currently available in the archive. Read it on SEC EDGAR ↗